Evidence map›Paper›PMID 35924576›Full record

ArticleHaematologica2022

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.

Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Frédéric Bauduer, Kaddour Chabane, Patrice Chevallier, Pascale Cony-Makhoul, Pascale Flandrin-Gresta, Caroline Le Jeune, Yannick Le Bris and 7 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. [Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
    Guideline
  2. Guideline
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Stephanie DulucqLaboratory of Hematology, University Hospital of Bordeaux, Pessac, France; Groupe Fi-LMC, Centre Léon Bérard, Lyon, France; Groupe GBMHM, Hôpital Saint Louis, Paris.
Sandrine HayetteGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Groupe GBMHM, Hôpital Saint Louis, Paris, France; Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite.
Jean-Michel CayuelaGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Groupe GBMHM, Hôpital Saint Louis, Paris, France; Laboratory of Hematology, Hôpital Saint Louis, Paris.
Frédéric BauduerGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Department of Hematology, Côte Basque Hospital, Bayonne.
Kaddour ChabaneLaboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite.
Patrice ChevallierHematology department, Hôtel Dieu, Nantes.
Pascale Cony-MakhoulGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Department of Hematology, Annecy-Genevois Hospital, Pringy.
Pascale Flandrin-GrestaGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Groupe GBMHM, Hôpital Saint Louis, Paris, France; Laboratory of Hematology, University Hospital of Saint-Etienne, Saint Etienne.
Caroline Le JeuneGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Department of Hematology, Institut de Cancérologie Lucien Neuwirth, Saint Etienne.
Yannick Le BrisGroupe GBMHM, Hôpital Saint Louis, Paris, France; Laboratory of Hematology, Hôtel Dieu, Nantes.
Laurence LegrosGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology department, Hôpital Paul Brousse, Villejuif.
Hervé MaisonneuveHematology and Oncology department, La Roche sur Yon Hospital, La Roche sur Yon.
Lydia RoyGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology department, Hôpital Henri Mondor, Créteil.
Francois-Xavier MahonGroupe GBMHM, Hôpital Saint Louis, Paris, France; Cancer Center of Bordeaux, lnstitut Bergonié, Bordeaux.
Ivan SlomaGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Groupe GBMHM, Hôpital Saint Louis, Paris, France; Laboratory of Hematology, Hôpital Henri Mondor, Créteil.
Delphine ReaGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology department, Hôpital Saint Louis, Paris.
Franck Emmanuel NicoliniGroupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology department and CRCL INSERM U1052, Centre Léon Bérard, Lyon. franck-emmanuel.nicolini@lyon.unicancer.fr.
Hôpital Saint-Louis · FRCentre Léon Bérard · FRCentre Hospitalier Départemental Vendée · FRCentre Hospitalier Universitaire de Saint-Étienne · FRHôpital Lyon Sud · FRHôpitaux Universitaires Henri-Mondor · FRHotel Dieu Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blast CrisisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansImatinib MesylateRemission InductionImatinib Mesylate

Identifiers

PMID35924576
PMCPMC9713569
OpenAlexW4289793368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.